SURMODICS INC — Director's Dealing 2015

May 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2015-05-11

Reporting Person: DANTZKER DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-11	Common Stock	S	11662	$24.7524	Disposed	9067	Direct

Footnotes

F1: Reflects the weighted average price of 11,662 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 11, 2015 with sale prices ranging from $24.70 to $24.88 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 4,207 restricted stock units (RSUs) that vest on service-based vesting dates and 4,360 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting persons' service as a director ends. In addition, the number of DSUs of the reporting person as last reported on a Form 4 filed on April 2, 2015 has been adjusted downward by one share to reflect the actual DSUs received by the reporting person in lieu of quarterly cash retainer payments to conform to the rounding convention of Surmodics, Inc. based on the closing stock price at the end of the quarter ended March 31, 2015.